Overview

A Safety/Efficacy Trial of Zonisamide for Essential Tremor

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to obtain information whether the medication zonisamide reduces tremor in persons with essential tremor and is well tolerated.
Phase:
Phase 2
Details
Lead Sponsor:
VA Greater Los Angeles Healthcare System
Collaborator:
Ralph M. Parsons Foundation
Treatments:
Zonisamide